Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Pre-Reg Required

CSP Icon

Livestreaming Session Icon

On-Demand Session

CIP Accredited

Additional Fee

CPIA Icon

Human Subjects Research

IACUC/Animal Care and Use

Crossover

Institutional Leadership

Deep Dive Series

Networking Series

Workshop Series

Vendor Insight Series

Thought Leader Series

Pillars Icon

Poster Icons

Record Session Icon

Pre-Reg Required

New for 2020

Part I/II

CSP Icon

Livestreaming Session Icon

Prerecorded Session Icon

CIP Accredited

Pillars Icon

Back

1,084 Views

Favorite

2022 PRIM&R Annual Conference

Pharma/Biotech Perspectives

Populations Requiring Additional Protections

Advancing Equity and Justice in Research

F03 - Compensation: How Much Inducement Is Due?

Thursday, December 15, 2022

11:45 AM – 12:45 PM ET

Location: Livestreamed

Speaker(s)

Brandon Brown, MPH, PhD

School of Medicine, University of California, Riverside
Riverside, California
ND

Neal W. Dickert, MD, PhD (he/him/his)

Emory University School of Medicine, Division of Cardiology
Emory University School of Medicine
EL

Emily Largent, RN, JD, PhD

Perelman School of Medicine, University of Pennsylvania
Philadelphia, Pennsylvania

Resource Person(s)

Jerry A. Menikoff, MD, JD

Office for Human Research Protections
Rockville, Maryland

Paying research participants in exchange for their participation is a common practice. Yet, there is confusion and disagreement regarding exactly what can be paid and how much is appropriate. There is general alignment among the research community that participants should be reimbursed for direct expenses incurred so they are not made worse off financially from their trial participation. Beyond this, the lines are fuzzy between what is fair and just compensation or incentives, and what could be considered undue inducement. This session will explore the ethical considerations between reimbursement, compensation, and incentives for trial participation, what constitutes undue inducement, and the pros and cons of different mechanisms for providing payments. In addition, there will be discussion of the role of the IRB in discharging risks of undue inducement.

Learning Objectives:

Identify considerations for determining the amount of payments to research participants (e.g., when the recipient of the payment is not the research participant or the acceptability of payments for assuming risk)
Consider the pros and cons of different payment mechanisms (e.g., gift cards vs cash) and timing of payments
Discuss the degree to which IRB review eliminates the possibility of undue inducement